2017年8月8日 / 晚上8点32分 / 14 天前

BRIEF-OpGen Q2 loss per share $0.15​

Aug 8 (Reuters) - OpGen Inc

* OpGen reports 2017 second quarter financial results and provides business update

* Q2 revenue $700,000 versus $1.2 million

* OpGen Inc qtrly ‍net loss per common share, basic and diluted, $0.15​

* OpGen - ‍first of rapid tests expected to be tested at third-party clinical evaluation sites in q4 and launched as an ruo test in first half of 2018​

* OpGen Inc - ‍cash and cash equivalents were $0.2 million as of June 30, 2017 compared with $4.1 million as of december 31, 2016​

* OpGen Inc - ‍expect a decrease in operating expenses of approximately 25% to 30% in second half of 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below